Breast cancer remains one of the most common cancers worldwide and continues to affect millions of women each year.

Because breast cancer is biologically diverse, researchers rely on well-characterized human biospecimens to investigate tumor biology, molecular alterations, biomarkers, disease progression, and treatment responses.

At Bay Biosciences, we understand this need and provide high-quality breast cancer tissue samples for research, including fresh-frozen tumor tissue, FFPE tissue, serum, plasma, peripheral blood mononuclear cells (PBMCs), and other human biospecimens for research and development purposes.

Breast Cancer Tissue Samples in Research

Understanding Breast Cancer

Breast cancer develops when abnormal cells in the breast grow uncontrollably and form a tumor.

These cancers can originate in different parts of the breast, including the milk ducts and milk-producing lobules.

Breast cancer is a biologically heterogeneous disease.

Tumors can differ in their histological features, hormone receptor status, HER2 expression, genetic alterations, stage, grade, and response to treatment.

Based on molecular and biomarker characteristics, this cancer type may be categorized into different subtypes:

These biological differences make appropriately characterized tumor and blood-derived specimens important for breast cancer research.

Signs and Symptoms of Breast Cancer

Early breast cancer may not cause noticeable symptoms. As the tumor develops, patients may experience changes in the breast or surrounding tissue.

Common signs and symptoms include:

  • A lump or thickening in the breast
  • Changes in breast size or shape
  • Changes in the appearance of the skin
  • Dimpling or indentation of the breast skin
  • Nipple changes or discharge
  • Nipple inversion
  • Persistent breast or nipple pain
  • Swelling in part or all of the breast
  • Enlarged lymph nodes under the arm or near the collarbone

Causes of Breast Cancer

The exact cause of breast cancer is not fully understood.

However, the disease develops through the accumulation of genetic and molecular changes that disrupt normal cellular growth and regulation.

Some genetic alterations are inherited, while others develop during a person’s lifetime.

Changes involving genes associated with DNA repair, cell growth, and tumor suppression can contribute to breast cancer development.

Similarly, hormonal factors can also influence breast cancer risk.

In addition, changes in reproductive history, exposure to certain environmental factors, and other biological processes also contribute to disease development.

Researchers continue to investigate how genetic, hormonal, environmental, and lifestyle factors interact to influence breast cancer development and progression.

Risk Factors for Breast Cancer

Several factors may increase the likelihood of developing breast cancer.

Firstly, advancing age is an important risk factor, with breast cancer occurring more frequently in older adults.

Secondly, inherited genetic alterations can increase susceptibility. Changes in genes such as BRCA1 and BRCA2 are associated with increased breast cancer risk.

Thirdly, reproductive and hormonal factors may influence risk. Longer lifetime exposure to estrogen and certain reproductive patterns have been associated with breast cancer development.

Finally, alcohol consumption, physical inactivity, excess body weight after menopause, and exposure to ionizing radiation may also contribute to breast cancer risk.

However, many people who develop breast cancer do not have a clearly identifiable risk factor other than sex and age. WHO estimates that approximately 80% of breast cancers occur in women without specific risk factors beyond these factors.

Diagnosis of Breast Cancer

Diagnosis generally begins with a clinical examination and imaging studies to identify suspicious abnormalities.

Mammography and breast ultrasound are commonly used to evaluate breast abnormalities, while magnetic resonance imaging (MRI) may be used in selected cases.

When imaging identifies a suspicious lesion, a biopsy may be performed to obtain breast tissue for pathological examination.

Pathologists examine the tissue to determine whether malignant cells are present and to characterize the tumor.

Tumor tissue may also undergo biomarker testing. Commonly evaluated biomarkers include estrogen receptor (ER), progesterone receptor (PR), HER2, and Ki-67.

These results provide information about tumor characteristics and may help guide treatment decisions.

Similarly, molecular and genomic testing may also identify specific alterations that can provide additional information about tumor biology and potential treatment strategies.

Treatment of Breast Cancer

Treatment depends on factors such as tumor subtype, stage, tumor size, lymph-node involvement, biomarker status, and the patient’s overall health.

Firstly, surgery may be performed to remove the tumor.

Procedures can include breast-conserving surgery or mastectomy, depending on the characteristics of the tumor.

Secondly, radiation therapy may be used after surgery or in other clinical settings to target remaining cancer cells.

Thirdly, chemotherapy may be used before or after surgery and is particularly important for certain aggressive or advanced breast cancers.

Hormone therapies may be used for hormone receptor-positive tumors, while HER2-targeted therapies may be used for appropriate HER2-positive cancers.

 

Immunotherapy is also used in selected breast cancer settings, including certain triple-negative breast cancers.

Researchers continue to evaluate targeted therapies, immunotherapies, combination treatments, and biomarker-guided approaches using clinical and laboratory research models.

Applications of Breast Cancer Tissue Samples for Research

Well-characterized breast cancer tissue samples for research can support a wide range of cancer research applications.

Triple Negative Breast Cancer Samples Research:

Triple-negative breast cancer samples research can help investigators study tumors that lack ER, PR, and HER2 expression. These samples support investigations into tumor biology, immune responses, molecular alterations, treatment resistance, and the development of new therapeutic strategies.

HER2 Positive Breast Cancer Tissue Samples:

HER2-positive breast cancer tissue samples can be used to investigate HER2 signaling, tumor characteristics, biomarker expression, therapeutic response, and mechanisms associated with resistance to HER2-targeted treatments.

Breast Cancer FFPE Tissue Samples:

Breast cancer FFPE tissue samples can provide preserved tumor material for histopathology, immunohistochemistry, biomarker evaluation, and molecular studies.

Fresh Frozen Breast Tumor Tissue Samples:

Fresh frozen breast tumor tissue samples can support molecular and genomic investigations where preservation of nucleic acids and other biological components is important.

Breast Cancer Biospecimens for Research:

Breast cancer biospecimens for research may include tumor tissue, serum, plasma, PBMCs, whole blood, and other patient-derived materials. Studying multiple specimen types can allow researchers to investigate both tumor characteristics and systemic biological responses.

Frequently Asked Questions

What are breast cancer tissue samples for research?

Breast cancer tissue samples for research are specimens collected from individuals diagnosed with breast cancer. Depending on the study, samples may be provided as fresh frozen tissue, FFPE tissue, or other processed formats.

What are breast cancer biospecimens for research used for?

Breast cancer biospecimens for research support studies of tumor biology, biomarkers, molecular characteristics, disease progression, treatment response, and therapeutic development.

What are breast cancer FFPE tissue samples used for?

Breast cancer FFPE tissue samples are used for histological examination, immunohistochemistry, biomarker studies, and selected molecular analyses.

Why are fresh frozen breast tumor tissue samples important?

Fresh frozen breast tumor tissue samples can preserve biological material suitable for various molecular and genomic research applications, including studies of DNA, RNA, proteins, and gene expression.

Supporting Your Research with Bay Biosciences

Bay Biosciences is a provider of human biospecimens for pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers.

Our high-quality samples support research involving breast cancer biology, biomarker discovery, molecular characterization, and therapeutic development.

Our comprehensive range of specimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us!